BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Lin J, Guo S, Xue X, Wang Y, Qiu S, Cui J, Ma L, Zhang X, Wang J. RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer. Cancer Cell Int 2020;20:587. [PMID: 33372599 DOI: 10.1186/s12935-020-01689-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang D, Wang J, Li C, Shi L, Zhang M. Ferroptosis-related gene model to predict overall survival of papillary thyroid carcinoma. Am J Otolaryngol 2021;42:103163. [PMID: 34339960 DOI: 10.1016/j.amjoto.2021.103163] [Reference Citation Analysis]
2 Tang B, Xu W, Wang Y, Zhu J, Wang H, Tu J, Weng Q, Kong C, Yang Y, Qiu R, Zhao Z, Xu M, Ji J. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death. Clin Immunol 2021;232:108872. [PMID: 34648954 DOI: 10.1016/j.clim.2021.108872] [Reference Citation Analysis]
3 Dai T, Li J, Lu X, Ye L, Yu H, Zhang L, Deng M, Zhu S, Liu W, Wang G, Yang Y. Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma. Pharmgenomics Pers Med 2021;14:927-45. [PMID: 34377010 DOI: 10.2147/PGPM.S319524] [Reference Citation Analysis]
4 Xu C, Liu Z, Xiao J. Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease. Int J Mol Sci 2021;22:12403. [PMID: 34830285 DOI: 10.3390/ijms222212403] [Reference Citation Analysis]
5 Li X, Huang J, Chen J, Zhan Y, Zhang R, Lu E, Li C, Zhang Y, Wang Y, Li Y, Zheng J, Geng W. A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma. Front Oncol 2021;11:726486. [PMID: 34966666 DOI: 10.3389/fonc.2021.726486] [Reference Citation Analysis]
6 Kusnick J, Bruneau A, Tacke F, Hammerich L. Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma. Immuno 2022;2:185-217. [DOI: 10.3390/immuno2010014] [Reference Citation Analysis]
7 Qi X, Fu Y, Sheng J, Zhang M, Zhang M, Wang Y, Li G. A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer. Bioengineered 2021;12:1813-25. [PMID: 33989111 DOI: 10.1080/21655979.2021.1925003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Qi X, Wang R, Lin Y, Yan D, Zuo J, Chen J, Shen B. A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer. Front Genet 2021;12:692426. [PMID: 34276794 DOI: 10.3389/fgene.2021.692426] [Reference Citation Analysis]
9 Si C, Zhou X, Deng J, Ye S, Kong L, Zhang B, Wang W. Role of ferroptosis in gastrointestinal tumors: From mechanisms to therapies. Cell Biol Int 2022. [PMID: 35476364 DOI: 10.1002/cbin.11804] [Reference Citation Analysis]
10 Ye L, Jin F, Kumar SK, Dai Y. The mechanisms and therapeutic targets of ferroptosis in cancer. Expert Opin Ther Targets 2021;:1-22. [PMID: 34821176 DOI: 10.1080/14728222.2021.2011206] [Reference Citation Analysis]
11 Lopes-Coelho F, Martins F, Hipólito A, Mendes C, Sequeira CO, Pires RF, Almeida AM, Bonifácio VDB, Pereira SA, Serpa J. The Activation of Endothelial Cells Relies on a Ferroptosis-Like Mechanism: Novel Perspectives in Management of Angiogenesis and Cancer Therapy. Front Oncol 2021;11:656229. [PMID: 34041026 DOI: 10.3389/fonc.2021.656229] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Wang Y, Chen W, Zhu M, Xian L. Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma. Front Mol Biosci 2021;8:692530. [PMID: 34395526 DOI: 10.3389/fmolb.2021.692530] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Teng Y, Wang B, Shang D, Yang N. Identification and Validation of an Immune and Ferroptosis-Combined Index for Non-Small Cell Lung Cancer. Front Genet 2021;12:764869. [PMID: 34917129 DOI: 10.3389/fgene.2021.764869] [Reference Citation Analysis]
14 Xiong W, Zhang B, Yu H, Zhu L, Yi L, Jin X. RRM2 Regulates Sensitivity to Sunitinib and PD-1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway. Adv Sci (Weinh) 2021;:e2100881. [PMID: 34319001 DOI: 10.1002/advs.202100881] [Reference Citation Analysis]
15 Jin Y, Wang Z, He D, Zhu Y, Gong L, Xiao M, Chen X, Cao K. Analysis of Ferroptosis-Mediated Modification Patterns and Tumor Immune Microenvironment Characterization in Uveal Melanoma. Front Cell Dev Biol 2021;9:685120. [PMID: 34386492 DOI: 10.3389/fcell.2021.685120] [Reference Citation Analysis]
16 Diao X, Guo C, Liu L, Wang G, Li S. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes. Thorac Cancer 2021. [PMID: 34672420 DOI: 10.1111/1759-7714.14195] [Reference Citation Analysis]
17 Zhou J, Wang X, Li Z, Jiang R. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma. FEBS Open Bio 2021;11:3005-18. [PMID: 34499810 DOI: 10.1002/2211-5463.13288] [Reference Citation Analysis]
18 Xu J, Su Z, Cheng X, Hu S, Wang W, Zou T, Zhou X, Song Z, Xia Y, Gao Y, Zheng Q. High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02508-y] [Reference Citation Analysis]